研究设计对人工智能辅助结肠镜腺瘤检出率影响的系统综述与荟萃分析
该系统综述与荟萃分析纳入24项随机对照试验(共17413例结肠镜检查),评估平行与串联设计对AI辅助结肠镜腺瘤检出率(ADR)的影响。结果显示AI辅助结肠镜总体改善ADR(RR 1.24,95%CI 1.17-1.31),串联与平行设计均显示改善且无统计学亚组差异。串联设计在每结肠镜腺瘤数改善更显著,且不增加退镜时间。
要点
- AI辅助结肠镜总体改善ADR(RR 1.24,95%CI 1.17-1.31)
- 串联与平行设计对ADR改善无统计学亚组差异
- 串联设计每结肠镜腺瘤数改善更显著且不增加退镜时间
核心结论
- 平行或串联研究设计均可捕捉AI辅助息肉检测系统带来的ADR改善。
- 串联设计通过配对比较检测内镜性能差异,可能是评估新AI辅助技术的高效方法。
研究设计与样本
- 系统检索Ovid MEDLINE、Embase、Cochrane Central、Web of Science和IEEE Xplore截至2023年3月1日的随机对照试验。
- 纳入24项随机对照试验,共17413例结肠镜检查(AI辅助8680例,非AI辅助8733例)。
- 采用随机效应模型进行汇总事件分析。
主要发现
- AI辅助结肠镜改善总体ADR(RR 1.24;95%CI 1.17-1.31;I2=53%;P<.001)。
- 串联研究显示AI辅助结肠镜改善ADR(RR 1.18;95%CI 1.08-1.30;I2=0%;P<.001)。
- 平行研究显示AI辅助结肠镜改善ADR(RR 1.26;95%CI 1.17-1.35;I2=62%;P<.001)。
- 研究设计间无统计学亚组差异;串联与平行设计均显示每结肠镜腺瘤数改善,但串联研究改善更显著(P<.001)。
- AI辅助显著增加平行研究的退镜时间(P=.002),但未增加串联研究的退镜时间;亚洲研究ADR改善较欧洲和北美更显著(P=.007)。
关键数值与推荐
- 主要结局为研究类型对ADR的影响;次要结局包括研究类型对每结肠镜腺瘤数和退镜时间的影响,以及地理区域、AI系统和内镜医师经验对ADR的影响。
临床怎么用
- 平行或串联设计均可用于评估AI辅助结肠镜对ADR的改善效果。
- 串联设计可能作为评估新AI辅助技术的高效方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Randomized controlled trials (RCTs) have reported that artificial intelligence (AI) improves endoscopic polyp detection. Different methodologies-namely, parallel and tandem designs-have been used to evaluate the efficacy of AI-assisted colonoscopy in RCTs. Systematic reviews and meta-analyses have reported a pooled effect that includes both study designs. However, it is unclear whether there are inconsistencies in the reported results of these 2 designs. Here, we aimed to determine whether study characteristics moderate between-trial differences in outcomes when evaluating the effectiveness of AI-assisted polyp detection. METHODS: A systematic search of Ovid MEDLINE, Embase, Cochrane Central, Web of Science, and IEEE Xplore was performed through March 1, 2023, for RCTs comparing AI-assisted colonoscopy with routine high-definition colonoscopy in polyp detection. The primary outcome of interest was the impact of study type on the adenoma detection rate (ADR). Secondary outcomes included the impact of the study type on adenomas per colonoscopy and withdrawal time, as well as the impact of geographic location, AI system, and endoscopist experience on ADR. Pooled event analysis was performed using a random-effects model. RESULTS: Twenty-four RCTs involving 17,413 colonoscopies (AI assisted: 8680; non-AI assisted: 8733) were included. AI-assisted colonoscopy improved overall ADR (risk ratio [RR], 1.24; 95% confidence interval [CI], 1.17-1.31; I2 = 53%; P < .001). Tandem studies collectively demonstrated improved ADR in AI-aided colonoscopies (RR, 1.18; 95% CI, 1.08-1.30; I2 = 0%; P < .001), as did parallel studies (RR, 1.26; 95% CI, 1.17-1.35; I2 = 62%; P < .001), with no statistical subgroup difference between study design. Both tandem and parallel study designs revealed improvement in adenomas per colonoscopy in AI-aided colonoscopies, but this improvement was more marked among tandem studies (P < .001). AI assistance significantly increased withdrawal times for parallel (P = .002), but not tandem, studies. ADR improvement was more marked among studies conducted in Asia compared to Europe and North America in a subgroup analysis (P = .007). Type of AI system used or endoscopist experience did not affect overall improvement in ADR. CONCLUSIONS: Either parallel or tandem study design can capture the improvement in ADR resulting from the use of AI-assisted polyp detection systems. Tandem studies powered to detect differences in endoscopic performance through paired comparison may be a resource-efficient method of evaluating new AI-assisted technologies.
引用
- Lee MCM, Parker CH, Liu LWC, et al. Impact of study design on adenoma detection in the evaluation of artificial intelligence-aided colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc. 2024. PMID: 38272274. doi:10.1016/j.gie.2024.01.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。